BFEC
ARNA

Benjamin F. Edwards & Company’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300
Closed -$14K – 1936
2019
Q4 		$14K Hold
300
– – ﹤0.01% 1336
2019
Q3 		$14K Hold
300
– – ﹤0.01% 1314
2019
Q2 		$18K Hold
300
– – ﹤0.01% 1240
2019
Q1 		$13K Sell
300
-500
-63% -$22.9K ﹤0.01% 1263
2018
Q4 		$31K Buy
+800
New +$31.4K ﹤0.01% 972

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Benjamin F. Edwards & Company's ARNA Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 300 shares — an estimated $14K sold.

Benjamin F. Edwards & Company first reported a position in ARNA in Q4 2018 and held it in 5 quarters. The position peaked at $31K in Q4 2018. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • Benjamin F. Edwards & Company reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 300 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $14K.
  • Benjamin F. Edwards & Company first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 5 quarters.
  • Benjamin F. Edwards & Company's Arena Pharmaceuticals Inc position peaked at $31K in Q4 2018.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.